首页> 外文期刊>Oncogene >Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients
【24h】

Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients

机译:具有 Th1 表型的骨髓辅助细胞在前体 B 急性淋巴细胞白血病患者中诱导白血病细胞的活化和增殖

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Precursor B cell acute lymphoblastic leukemia (BCP-ALL) constitutes the leading cause of cancer-related death in children. While chromosomal alterations contribute to BCP-ALL pathogenesis, they are insufficient for leukemia development. Epidemiological data and evidence from a mouse model suggest that immune responses to infections may trigger the emergence of leukemia, but the mechanisms remain unclear. Here, we show that T helper (Th) cells from bone marrow of pediatric BCP-ALL patients can be attracted and activated by autologous BCP-ALL cells. Bone-marrow Th cells supportively interacted with BCP-ALL cells, inducing upregulation of important surface molecules and BCP-ALL cell proliferation. These Th cells displayed a Th1-like phenotype and produced high levels of IFN-gamma. IFN-gamma was responsible for the upregulation of CD38 in BCP-ALL cells, a molecule which we found to be associated with early relapse, and accountable for the production of IP-10, a chemokine involved in BCP-ALL migration and drug resistance. Thus, our data provide mechanistic support for an involvement of Th cell immune responses in the propagation of BCP-ALL and suggest that BCP-ALL cell-supportive Th cells may serve as therapeutic target.
机译:前体B细胞急性淋巴细胞白血病(BCP-ALL)是儿童癌症相关死亡的主要原因。虽然染色体改变有助于 BCP-ALL 发病机制,但它们不足以导致白血病的发展。来自小鼠模型的流行病学数据和证据表明,对感染的免疫反应可能引发白血病的出现,但其机制尚不清楚。在这里,我们表明来自儿科 BCP-ALL 患者骨髓的 T 辅助性 (Th) 细胞可以被自体 BCP-ALL 细胞吸引和激活。骨髓Th细胞与BCP-ALL细胞支持性相互作用,诱导重要表面分子的上调和BCP-ALL细胞增殖。这些Th细胞显示出Th1样表型,并产生高水平的IFN-γ。IFN-γ 负责 BCP-ALL 细胞中 CD38 的上调,我们发现这种分子与早期复发有关,并负责产生 IP-10,IP-10 是一种参与 BCP-ALL 迁移和耐药性的趋化因子。因此,我们的数据为 Th 细胞免疫反应参与 BCP-ALL 的传播提供了机制支持,并表明 BCP-ALL 细胞支持 Th 细胞可能作为治疗靶点。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号